Trial: 202003064

Phase I/II Study of Pamiparib (BGB-290) with Temozolomide in Recurrent Gliomas with IDH1/2 Mutations

Phase

I/II

Principal Investigator

Chheda, Milan

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov